Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs to Market Synthetic Genomics' DNA Fragment Assembly Tech


New England Biolabs and Synthetic Genomics have inked a licensing deal that will allow NEB to market a master mix based on Gibson Assembly technology for molecular and synthetic biology applications, the companies said this week.

The Gibson Assembly master mix was developed by Daniel Gibson and colleagues at the J. Craig Venter Institute as part of a program sponsored by La Jolla, Calif.-based Synthetic Genomics. Introduced in 2009, the method uses a one-step, isothermal approach to enable the rapid assembly of multiple DNA fragments.

The Gibson Assembly master mix includes protocols for primer design, and can be used to assemble multiple DNA fragments, including linearized vector and insert, into larger genetic constructs. NEB, based in Ipswich, Mass., now offers the master mix through its website, the company said.

The companies did not disclose financial details of the agreement.

SGI also noted that it recently signed an agreement with Integrated DNA Technologies to manufacture, market, and commercialize custom synthetic double-stranded nucleic acids of lengths up to 5 kb using SGI's proprietary technologies.